Hypoglycemic treatment of type 2 diabetes
Thorsby, P.; Kilhovd, B.; Sletmo, R.; Martinsen, S.; Birkeland, K.I.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2434-2440
2000
ISSN/ISBN: 0029-2001 PMID: 11475233 Document Number: 514683
Hyperglycaemia in type 2 diabetes results from reduced beta-cell function and insulin resistance. The treatment of type 2 diabetes must be targeted against both conditions to reduce symptoms of hyperglycaemia and the risk of diabetic late complications. In this review we cover the recent scientific documentation from long term studies on treatment effects. We also discuss the different treatments available. Recent clinical trials have shown that lowering blood glucose levels over time significantly reduces development of microvascular complications in type 2 diabetes. There are several treatment options available which make adequate blood glucose control possible in patients with type 2 diabetes. A reduction in the development of microvascular complications in type 2 diabetes is an achievable goal.